{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:05:52Z","timestamp":1782821152585,"version":"3.54.5"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12020-019-01859-3","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T10:22:11Z","timestamp":1550226131000},"page":"591-604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Association and gene\u2013gene interaction analyses for polymorphic variants in CTLA-4 and FOXP3 genes: role in susceptibility to autoimmune thyroid disease"],"prefix":"10.1007","volume":"64","author":[{"given":"Nusrath","family":"Fathima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1582-6660","authenticated-orcid":false,"given":"Parimala","family":"Narne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Ishaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"1859_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1210\/er.2013-1055","volume":"35","author":"SM McLachlan","year":"2014","unstructured":"S.M. McLachlan, B. Rapoport, Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr. Rev. 35, 59\u2013105 (2014). \n                    https:\/\/doi.org\/10.1210\/er.2013-1055","journal-title":"Endocr. Rev."},{"key":"1859_CR2","unstructured":"A.P. Weetman, Chronic autoimmune thyroiditis. in ed. by L.E. Braverman, R.D. Utiger, Werner and Ingbar\u2019s The Thyroid (Lippincott Williams and Wilkins, Philadelphia, 2000), pp. 721\u2013732"},{"key":"1859_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","volume":"117","author":"C Dejaco","year":"2006","unstructured":"C. Dejaco, C. Duftner, B. Grubeck-Loebenstein, M. Schirmer, Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117, 289\u2013300 (2006)","journal-title":"Immunology"},{"key":"1859_CR4","doi-asserted-by":"publisher","unstructured":"A. Kitz, E. Singer, D. Hafler, Regulatory T cells: from discovery to autoimmunity. Cold Spring Harb. Perspect. Med. (2018). \n                    https:\/\/doi.org\/10.1101\/cshperspect.a029041\n                    \n                  .","DOI":"10.1101\/cshperspect.a029041"},{"key":"1859_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coi.2016.07.004","volume":"43","author":"AM Pesenacker","year":"2016","unstructured":"A.M. Pesenacker, L. Cook, M.K. Levings, The role of FOXP3 in autoimmunity. Curr. Opin. Immunol. 43, 16\u201323 (2016). \n                    https:\/\/doi.org\/10.1016\/j.coi.2016.07.004","journal-title":"Curr. Opin. Immunol."},{"key":"1859_CR6","first-page":"930","volume":"86","author":"TH Brix","year":"2001","unstructured":"T.H. Brix, K.O. Kyvik, K. Christensen, L. Hegedus, Evidence for a major role of heredity in Graves\u2019 disease: a population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab. 86, 930\u2013934 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1859_CR7","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1210\/jc.2002-020492","volume":"87","author":"B Vaidya","year":"2002","unstructured":"B. Vaidya, P. Kendall-Taylor, S.H. Pearce, The genetics of autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 87, 5385\u20135397 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1859_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jaut.2009.02.007","volume":"32","author":"Y Tomer","year":"2009","unstructured":"Y. Tomer, A. Huber, The etiology of autoimmune thyroid disease: a story of genes and environment. J. Autoimmun. 32, 231\u2013239 (2009)","journal-title":"J. Autoimmun."},{"key":"1859_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaut.2015.07.009","volume":"64","author":"HJ Lee","year":"2015","unstructured":"H.J. Lee, C.W. Li, S.S. Hammerstad, M. Stefan, Y. Tomer, Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J. Autoimmun. 64, 82\u201390 (2015). \n                    https:\/\/doi.org\/10.1016\/j.jaut.2015.07.009.","journal-title":"J. Autoimmun."},{"issue":"7","key":"1859_CR10","doi-asserted-by":"publisher","first-page":"E1387","DOI":"10.1210\/jc.2013-4358","volume":"99","author":"RS Brown","year":"2014","unstructured":"R.S. Brown, A. Lombardi, A. Hasham, D.A. Greenberg, J. Gordon, E. Concepcion, S.S. Hammerstad, V. Lotay, W. Zhang, Y. Tomer, Genetic analysis in young-age-of-onset Graves\u2019 disease reveals new susceptibility loci. J. Clin. Endocrinol. Metab. 99(7), E1387\u2013E1391 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1859_CR11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/hmg\/8.7.1195","volume":"8","author":"B Vaidya","year":"1999","unstructured":"B. Vaidya, H. Imrie, P. Perros, E.T. Young, W.F. Kelly, D. Carr, D.M. Large, A.D. Toft, M.I. McCarthy, P. Kendall-Taylor, S.H. Pearce, The cytotoxic T lymphocyte antigen-4 is a major Graves\u2019 disease locus. Hum. Mol. Genet. 8, 1195\u20131199 (1999)","journal-title":"Hum. Mol. Genet."},{"key":"1859_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"H. Ueda, J.M. Howson, L. Esposito, J. Heward, H. Snook et al.. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506\u2013511 (2003)","journal-title":"Nature"},{"key":"1859_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaut.2007.02.006","volume":"28","author":"EM Jacobson","year":"2007","unstructured":"E.M. Jacobson, Y. Tomer, The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J. Autoimmun. 28, 85\u201398 (2007)","journal-title":"J. Autoimmun."},{"key":"1859_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12997","volume":"190","author":"N Verma","year":"2017","unstructured":"N. Verma, S.O. Burns, L.S.K. Walker, D.M. Sansom, Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations. Clin. Exp. Immunol. 190, 1\u20137 (2017). \n                    https:\/\/doi.org\/10.1111\/cei.12997","journal-title":"Clin. Exp. Immunol."},{"key":"1859_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","volume":"1","author":"TL Walunas","year":"1994","unstructured":"T.L. Walunas, D.J. Lenschow, C.Y. Bakker, P.S. Linsley, G.J. Freeman, J.M. Greene, C.B. Thompson, J.A. Bluestone, CTLA-4 can function as a negative regulator of T-cell activation. Immunity 1, 405\u2013413 (1994)","journal-title":"Immunity"},{"key":"1859_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fendo.2016.00021","volume":"7","author":"A Lombardi","year":"2016","unstructured":"A. Lombardi, F. Menconi, D. Greenberg, E. Concepcion, M. Leo, R. Rocchi, M. Marin\u00f3, M. Keddache, Y. Tomer, Dissecting the genetic susceptibility to Graves\u2019 disease in a cohort of patients of Italian origin. Front. Endocrinol. (Lausanne) 7, 21 (2016)","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"1859_CR17","first-page":"41","volume":"80","author":"T Yanagawa","year":"1995","unstructured":"T. Yanagawa, Y. Hidaka, V. Guimaraes, M. Soliman, L.J. DeGroot, CTLA-4 gene polymorphism associated with Graves\u2019 disease in a Caucasian population. J. Clin. Endocrinol. Metab. 80, 41\u201345 (1995)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1859_CR18","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/hmg\/5.7.1075","volume":"5","author":"L Nistico\u0300","year":"1996","unstructured":"L. Nistico\u0300, R. Buzzetti, L.E. Pritchard, B. Van der Auwera, C. Giovannini, E. Bosi, M.T. Larrad, M.S. Rios, C.C. Chow, C.S. Cockram, K. Jacobs, C. Mijovic, S.C. Bain, A.H. Barnett, C.L. Vandewalle, F. Schuit, F.K. Gorus, R. Tosi, P. Pozzilli, J.A. Todd, The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum. Mol. Genet. 5, 1075\u20131080 (1996).","journal-title":"Hum. Mol. Genet."},{"key":"1859_CR19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1089\/thy.1997.7.843","volume":"7","author":"T Yanagawa","year":"1997","unstructured":"T. Yanagawa, M. Taniyama, S. Enomoto, K. Gomi, H. Maruyama, Y. Ban, T. Saruta, CTLA4 gene polymorphism confers susceptibility to Graves\u2019 disease in Japanese. Thyroid 7, 843\u2013846 (1997)","journal-title":"Thyroid"},{"key":"1859_CR20","first-page":"143","volume":"82","author":"H Donner","year":"1997","unstructured":"H. Donner, H. Rau, P.G. Walfish, J. Braun et al.. CTLA4 alanine-17 confers genetic susceptibility to Graves\u2019 disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 82, 143\u2013146 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1859_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2337\/diab.47.1.128","volume":"47","author":"T Awata","year":"1998","unstructured":"T. Awata, S. Kurihara, M. Iitaka, S. Takei et al.. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves\u2019 disease and Hashimoto\u2019s thyroiditis) in the Japanese population. Diabetes 47, 128\u2013129 (1998)","journal-title":"Diabetes"},{"key":"1859_CR22","first-page":"2398","volume":"84","author":"JM Heward","year":"1999","unstructured":"J.M. Heward, A. Allahabadia, M. Armitage, A. Hattersley, P.M. Dodson, K. Macleod, J. Carr-Smith, J. Daykin, A. Daly, M.C. Sheppard, R.L. Holder, A.H. Barnett, J.A. Franklyn, S.C. Gough, The development of Graves\u2019 disease and the CTLA-4 gene on chromosome 2q33. J. Clin. Endocrinol. Metab. 84, 2398\u20132401 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1859_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1089\/thy.2000.10.453","volume":"10","author":"YJ Park","year":"2000","unstructured":"Y.J. Park, H.K. Chung, D.J. Park, W.B. Kim, S.W. Kim, J.J. Koh, B.Y. Cho, Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10, 453\u2013459 (2000)","journal-title":"Thyroid"},{"key":"1859_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/thy.2006.16.237","volume":"16","author":"HJ Cho","year":"2006","unstructured":"H.J. Cho, J.H. Chung, I.S. Kim, H.J. Kim, S.H. Cho, C.S. Ki, J.W. Kim, Lack of a genetic association between the CTLA-4 gene and Graves\u2019 disease in Koreans. Thyroid 16, 237\u2013241 (2006)","journal-title":"Thyroid"},{"key":"1859_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1006\/clim.2001.5121","volume":"101","author":"H Hadj Kacem","year":"2001","unstructured":"H. Hadj Kacem, M. Bellassoued, N. Bougacha-Elleuch, M. Abid, H. Ayadi, CTLA-4 gene polymorphisms in Tunisian patients with Graves\u2019 disease. Clin. Immunol. 101, 361\u2013365 (2001)","journal-title":"Clin. Immunol."},{"key":"1859_CR26","first-page":"4130","volume":"82","author":"H Donner","year":"1997","unstructured":"H. Donner, J. Braun, C. Seidl, H. Rau, R. Finke, M. Ventz, P.G. Walfish, K.H. Usadel, K. Badenhoop, Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto\u2019s thyroiditis and Addison\u2019s disease. J. Clin. Endocrinol. Metab. 82, 4130\u20134132 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1859_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/105072501300042901","volume":"11","author":"A Petrone","year":"2001","unstructured":"A. Petrone, G. Giorgi, C.A. Mesturino, M. Capizzi, I. Cascino, L. Nistico, J. Osborn, U. Di Mario, R. Buzzetti, Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto\u2019s thyroiditis in an Italian population. Thyroid 11, 171\u2013175 (2001)","journal-title":"Thyroid"},{"key":"1859_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/105072502753451896","volume":"12","author":"R Nithiyananthan","year":"2002","unstructured":"R. Nithiyananthan, J.M. Heward, A. Allahabadia, J.A. Franklyn, S.C. Gough, Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 12, 3\u20136 (2002)","journal-title":"Thyroid"},{"key":"1859_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.gene.6364445","volume":"9","author":"PL Chen","year":"2008","unstructured":"P.L. Chen, C.S. Fann, C.C. Chang, I.L. Wu, W.Y. Chiu, C.Y. Lin, W.S. Yang, T.C. Chang, Family-based association study of cytotoxic T-lymphocyte antigen-4 with susceptibility to Graves\u2019 disease in Han population of Taiwan. Genes Immun. 9, 87\u201392 (2008)","journal-title":"Genes Immun."},{"key":"1859_CR30","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.humimm.2009.06.016","volume":"70","author":"A Bicek","year":"2009","unstructured":"A. Bicek, K. Zaletel, S. Gaberscek, E. Pirnat, B. Krhin, T.G. Stopar, S. Hojker, 49A\/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease. Hum. Immunol. 70, 820\u2013824 (2009). \n                    https:\/\/doi.org\/10.1016\/j.humimm.2009.06.016","journal-title":"Hum. Immunol."},{"key":"1859_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12020-011-9510-1","volume":"41","author":"J Yang","year":"2012","unstructured":"J. Yang, Q. Qin, N. Yan, Y.F. Zhu, C. Li, X.J. Yang, X. Wang, M. Pandey, P. Hou, J.A. Zhang, CD40 C\/T(-1) and CTLA-4 A\/G(49) SNPs are associated with autoimmune thyroid diseases in the Chinese population. Endocrine 41, 111\u2013115 (2012). \n                    https:\/\/doi.org\/10.1007\/s12020-011-9510-1","journal-title":"Endocrine"},{"key":"1859_CR32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s12020-013-0014-z","volume":"44","author":"M Feng","year":"2013","unstructured":"M. Feng, F.B. Zhang, H.R. Deng, The CTLA4+ 49A\/G polymorphism is associated with an increased risk of Hashimoto\u2019s thyroiditis in Asian but not Caucasian populations: an updated meta-analysis. Endocrine 44, 350\u2013358 (2013). \n                    https:\/\/doi.org\/10.1007\/s12020-013-0014-z","journal-title":"Endocrine"},{"key":"1859_CR33","doi-asserted-by":"publisher","unstructured":"H.F. Hou, X. Jin, T. Sun, C. Li, B.F. Jiang, Q.W. Li, Cytotoxic T lymphocyte-associated antigen 4 gene polymorphisms and autoimmune thyroid diseases: an updated systematic review and cumulative meta-analysis. Int. J. Endocrinol. 747816 (2015). \n                    https:\/\/doi.org\/10.1155\/2015\/747816","DOI":"10.1155\/2015\/747816"},{"key":"1859_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1677\/jme.1.02072","volume":"37","author":"CJ Owen","year":"2006","unstructured":"C.J. Owen, J.A. Eden, C.E. Jennings, V. Wilson, T.D. Cheetham, S.H. Pearce, Genetic association studies of the FOXP3 gene in Graves\u2019 disease and autoimmune Addison\u2019s disease in the United Kingdom population. J. Mol. Endocrinol. 37, 97\u2013104 (2006)","journal-title":"J. Mol. Endocrinol."},{"key":"1859_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1365-2249.2010.04229.x","volume":"162","author":"N Inoue","year":"2010","unstructured":"N. Inoue, M. Watanabe, M. Morita, R. Tomizawa, T. Akamizu, K. Tatsumi, Y. Hidaka, Y. Iwatani, Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin. Exp. Immunol. 162, 402\u2013406 (2010). \n                    https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04229.x","journal-title":"Clin. Exp. Immunol."},{"key":"1859_CR36","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.humimm.2013.08.270","volume":"74","author":"Y He","year":"2013","unstructured":"Y. He, H. Na, Y. Li, Z. Qiu, W. Li, FoxP3 rs3761548 polymorphism predicts autoimmune disease susceptibility: a meta-analysis. Hum. Immunol. 74, 1665\u20131667 (2013). \n                    https:\/\/doi.org\/10.1016\/j.humimm.2013.08.270","journal-title":"Hum. Immunol."},{"key":"1859_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/08916934.2014.910767","volume":"47","author":"A Bossowski","year":"2014","unstructured":"A. Bossowski, H. Borysewicz-Sa\u0144czyk, N. Wawrusiewicz-Kurylonek, A. Zasim, M. Szalecki, B. Wikiera et al.. Analysis of chosen polymorphisms in FoxP3 gene in children and adolescents with autoimmune thyroid diseases. Autoimmunity 47, 395\u2013400 (2014). \n                    https:\/\/doi.org\/10.3109\/08916934.2014.910767","journal-title":"Autoimmunity"},{"key":"1859_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.intimp.2015.02.020","volume":"25","author":"L Zheng","year":"2015","unstructured":"L. Zheng, X. Wang, L. Xu, N. Wang, P. Cai, T. Liang, L. Hu, Foxp3 gene polymorphisms and haplotypes associate with susceptibility of Graves\u2019 disease in Chinese Han population. Int. Immunopharmacol. 25, 425\u2013431 (2015). \n                    https:\/\/doi.org\/10.1016\/j.intimp.2015.02.020","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"1859_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/08916934.2015.1045582","volume":"48","author":"MG Lee","year":"2015","unstructured":"M.G. Lee, S.C. Bae, Y.H. Lee, Association between FOXP3 polymorphisms and susceptibility to autoimmune diseases: a meta-analysis. Autoimmunity 48(7), 445\u2013452 (2015). \n                    https:\/\/doi.org\/10.3109\/08916934.2015.1045582","journal-title":"Autoimmunity"},{"issue":"12","key":"1859_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/1721727X17714708","volume":"15","author":"M Yu","year":"2017","unstructured":"M. Yu, X. Tan, Y. Huang, FoxP3 variants are associated with susceptibility to Grave\u2019s disease in Chinese population. Eur. J. Inflamm. 15(12), 113\u2013119 (2017)","journal-title":"Eur. J. Inflamm."},{"key":"1859_CR41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","volume":"3","author":"EA Tivol","year":"1995","unstructured":"E.A. Tivol, F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, A.H. Sharpe, Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction: revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541\u2013547 (1995)","journal-title":"Immunity"},{"key":"1859_CR42","doi-asserted-by":"publisher","first-page":"46478","DOI":"10.1074\/jbc.M206894200","volume":"277","author":"S Anjos","year":"2002","unstructured":"S. Anjos, A. Nguyen, H. Ounissi-Benkalha, M.C. Tessier, C. Polychronakos, A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J. Biol. Chem. 277, 46478\u201346486 (2002)","journal-title":"J. Biol. Chem."},{"issue":"3","key":"1859_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/bjd.12377","volume":"169","author":"P Song","year":"2013","unstructured":"P. Song, X.W. Wang, H.X. Li, K. Li, L. Liu, C. Wei, Z. Jian, X.L. Yi, Q. Li, G. Wang, C.Y. Li, T.W. Gao, Association between FOXP3 polymorphisms and vitiligo in a Han Chinese population. Br. J. Dermatol. 169(3), 571\u2013578 (2013)","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"1859_CR44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/bioinformatics\/btf869","volume":"19","author":"LW Hahn","year":"2003","unstructured":"L.W. Hahn, M.D. Ritchie, J.H. Moore, Multifactor dimensionality reduction software for detecting gene\u2013gene and gene\u2013environment interactions. Bioinformatics 19(3), 376\u2013382 (2003)","journal-title":"Bioinformatics"},{"key":"1859_CR45","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.1131078","volume":"313","author":"H Schneider","year":"2006","unstructured":"H. Schneider, J. Downey, A. Smith, B.H. Zinselmeyer, C. Rush, J.M. Brewer, B. Wei, N. Hogg, P. Garside, C.E. Rudd, Reversal of the TCR stop signal by CTLA-4. Science 313, 1972\u20131975 (2006)","journal-title":"Science"},{"key":"1859_CR46","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","volume":"165","author":"T Kouki","year":"2000","unstructured":"T. Kouki, Y. Sawai, C.A. Gardine, M.E. Fisfalen, M.L. Alegre, L.J. DeGroot, CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves\u2019 disease. J. Immunol. 165, 6606\u20136611 (2000)","journal-title":"J. Immunol."},{"key":"1859_CR47","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/BF03343992","volume":"25","author":"T Kouki","year":"2002","unstructured":"T. Kouki, C.A. Gardine, T. Yanagawa, L.J. Degroot, Relation of three polymorphisms of the CTLA-4 gene in patients with Graves\u2019 disease. J. Endocrinol. Invest. 25, 208\u2013213 (2002)","journal-title":"J. Endocrinol. Invest."},{"key":"1859_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009821","volume":"5","author":"SX Zhao","year":"2010","unstructured":"S.X. Zhao, C.M. Pan, H.M. Cao et al.. Association of the CTLA4 gene with Graves\u2019 disease in the Chinese Han population. PLoS ONE 5, e9821 (2010). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0009821","journal-title":"PLoS ONE"},{"key":"1859_CR49","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1046\/j.1365-2265.2003.01778.x","volume":"58","author":"B Vaidya","year":"2003","unstructured":"B. Vaidya, E.J. Oakes, H. Imrie, A.J. Dickinson, P. Perros, P. Kendall-Taylor, S.H. Pearce, CTLA4 gene and Graves\u2019 disease: association of Graves\u2019 disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Clin. Endocrinol. (Oxf.) 58, 732\u2013735 (2003)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"1859_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059349","volume":"8","author":"B Jurecka-Lubieniecka","year":"2013","unstructured":"B. Jurecka-Lubieniecka, R. Ploski, D. Kula, A. Krol, T. Bednarczuk, Z. Kolosza, A. Tukiendorf, S. Szpak-Ulczok, A. Stanjek-Cichoracka, J. Polanska, B. Jarzab, Association between age at diagnosis of Graves\u2019 disease and variants in genes involved in immune response. PLoS ONE 8, e59349 (2013). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0059349","journal-title":"PLoS ONE"},{"key":"1859_CR51","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12020-016-1096-1","volume":"55","author":"E Pawlak-Adamska","year":"2017","unstructured":"E. Pawlak-Adamska, I. Frydecka, M. Bolanowski, A. Tomkiewicz et al.. CD28\/CTLA-4\/ICOS haplotypes confers susceptibility to Graves\u2019 disease and modulates clinical phenotype of disease. Endocrine 55, 186\u2013199 (2017). \n                    https:\/\/doi.org\/10.1007\/s12020-016-1096-1","journal-title":"Endocrine"},{"key":"1859_CR52","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1046\/j.1365-2265.1997.1710996.x","volume":"46","author":"K Kotsa","year":"1997","unstructured":"K. Kotsa, P.F. Watson, A.P. Weetman, A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin. Endocrinol. (Oxf.) 46, 551\u2013554 (1997)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"1859_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149441","volume":"11","author":"H Patel","year":"2016","unstructured":"H. Patel, M.S. Mansuri, M. Singh, R. Begum, M. Shastri, A. Misra, Association of cytotoxic T-lymphocyte antigen 4 (CTLA4) and thyroglobulin (TG) genetic variants with autoimmune hypothyroidism. PLoS One 11, e0149441 (2016). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0149441","journal-title":"PLoS One"},{"key":"1859_CR54","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.gene.2017.11.057","volume":"642","author":"S Ramgopal","year":"2018","unstructured":"S. Ramgopal, C. Rathika, M.R. Padma, V. Murali, K. Arun, M.N. Kamaludeen, K. Balakrishnan, Interaction of HLA-DRB1* alleles and CTLA4 (+49 AG) gene polymorphism in autoimmune thyroid disease. Gene 642, 430\u2013438 (2018). \n                    https:\/\/doi.org\/10.1016\/j.gene.2017.11.057","journal-title":"Gene"},{"key":"1859_CR55","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1210\/jc.2007-0147","volume":"92","author":"FK Kavvoura","year":"2007","unstructured":"F.K. Kavvoura, T. Akamizu, T. Awata, Y. Ban, D.A. Chistiakov et al.. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J. Clin. Endocrinol. Metab. 92, 3162\u20133170 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1859_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-489","volume":"7","author":"S Furqan","year":"2014","unstructured":"S. Furqan, N.U. Haque, N. Islam, Conversion of autoimmune hypothyroidism to hyperthyroidism. BMC Res. Notes 7, 489 (2014). \n                    https:\/\/doi.org\/10.1186\/1756-0500-7-489","journal-title":"BMC Res. Notes"},{"key":"1859_CR57","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12020-013-9985-z","volume":"45","author":"H Qiu","year":"2014","unstructured":"H. Qiu, W. Tang, P. Yin, F. Cheng, L. Wang, Cytotoxic T-lymphocyte associated antigen 4 polymorphism and Hashimoto\u2019s thyroiditis susceptibility: a meta-analysis. Endocrine 45, 198\u2013205 (2014). \n                    https:\/\/doi.org\/10.1007\/s12020-013-9985-z.","journal-title":"Endocrine"},{"key":"1859_CR58","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1089\/gtmb.2017.0243","volume":"22","author":"Y Hu","year":"2018","unstructured":"Y. Hu, K. Xu, L. Jiang, L. Zhang, H. Shi, D. Cui, Associations between three CTLA-4 polymorphisms and Hashimoto\u2019s thyroiditis risk: an updated meta-analysis with trial sequential analysis. Genet. Test. Mol. Biomark. 22, 224\u2013236 (2018). \n                    https:\/\/doi.org\/10.1089\/gtmb.2017.0243.","journal-title":"Genet. Test. Mol. Biomark."},{"key":"1859_CR59","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s10875-012-9721-0","volume":"32","author":"N Inoue","year":"2012","unstructured":"N. Inoue, M. Watanabe, H. Yamada, K. Takemura, F. Hayashi et al.. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies. J. Clin. Immunol. 32, 1243\u20131252 (2012). \n                    https:\/\/doi.org\/10.1007\/s10875-012-9721-0","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"1859_CR60","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4103\/2230-8210.113755","volume":"17","author":"AG Unnikrishnan","year":"2013","unstructured":"A.G. Unnikrishnan, S. Kalra, R.K. Sahay, G. Bantwal, M. John, N. Tewari, Prevalence of hypothyroidism in adults: an epidemiological study in eight cities of India. Indian J. Endocrinol. Metab. 17(4), 647\u2013652 (2013).","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"3","key":"1859_CR61","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","volume":"35","author":"ST Ngo","year":"2014","unstructured":"S.T. Ngo, F.J. Steyn, P.A. McCombe, Gender differences in autoimmune disease. Front. Neuroendocrinol. 35(3), 347\u2013369 (2014)","journal-title":"Front. Neuroendocrinol."},{"issue":"2","key":"1859_CR62","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1089\/thy.2014.0318","volume":"25","author":"N Ishido","year":"2015","unstructured":"N. Ishido, N. Inoue, M. Watanabe, Y. Hidaka, Y. Iwatani, The relationship between skewed X chromosome inactivation and the prognosis of Graves\u2019 and Hashimoto\u2019s diseases. Thyroid 25(2), 256\u2013261 (2015)","journal-title":"Thyroid"},{"key":"1859_CR63","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1530\/EJE-09-0600","volume":"161","author":"J Daroszewski","year":"2009","unstructured":"J. Daroszewski, E. Pawlak, L. Karabon, I. Frydecka, A. Jonkisz, M. Slowik, M. Bolanowski, Soluble CTLA-4 receptor an immunological marker of Graves\u2019 disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms. Eur. J. Endocrinol. 161, 787\u2013793 (2009)","journal-title":"Eur. J. Endocrinol."},{"key":"1859_CR64","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1089\/thy.2009.0066","volume":"19","author":"H Kimura","year":"2009","unstructured":"H. Kimura, Y. Kato, S. Shimizu, K. Takano, K. Sato, Association of polymorphism at position 49 in exon 1 of the cytotoxic T-lymphocyte-associated factor 4 gene with Graves\u2019 disease refractory to medical treatment, but not with amiodarone-associated thyroid dysfunction. Thyroid 19, 975\u2013981 (2009). \n                    https:\/\/doi.org\/10.1089\/thy.2009.0066.","journal-title":"Thyroid"},{"key":"1859_CR65","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1210\/jc.2006-2761","volume":"92","author":"PW Wang","year":"2007","unstructured":"P.W. Wang, I.Y. Chen, R.T. Liu, C.J. Hsieh, E. Hsi, S.H. Juo, Cytotoxic T lymphocyte-associated molecule-4 gene polymorphism and hyperthyroid Graves\u2019 disease relapse after antithyroid drug withdrawal: a follow-up study. J. Clin. Endocrinol. Metab. 92, 2513\u20132518 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1859_CR66","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12020-006-0017-0","volume":"30","author":"S Tanrikulu","year":"2006","unstructured":"S. Tanrikulu, Y. Erbil, E. Ademoglu, H. I\u015fsever, U. Barbaros, F. Kutlut\u00fcrk, S. Ozarmagan, S. Tezelman, The predictive value of CTLA-4 and Tg polymorphisms in the recurrence of Graves\u2019 disease after antithyroid withdrawal. Endocrine 30, 377\u2013381 (2006)","journal-title":"Endocrine"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-019-01859-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01859-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01859-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T19:26:10Z","timestamp":1581708370000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-019-01859-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1859"],"URL":"https:\/\/doi.org\/10.1007\/s12020-019-01859-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]},"assertion":[{"value":"27 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}